Pulse methotrexate versus pulse actinomycin D in the treatment of low‐risk gestational trophoblastic neoplasia
Fariba Yarandi(University of Tehran), Parviz Hanjani(Abington Memorial Hospital), Soheyla Kanani(University of Tehran), Zahra Eftekhar(University of Tehran), Hadi Shojaei(Cooper University Health Care), Ali Sharifi(University of Tehran)
Cited by 68
Related Papers
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
|Molecular Cancer|2014|559
Efficacy of Megestrol Acetate (Megace) in the Treatment of Patients With Early Endometrial Adenocarcinoma: Our Experiences With 21 Patients
|International Journal of Gynecological Cancer|2009|65
Chronic Pain after Spinal Cord Injury: Results of a Long-Term Study
|Pain Medicine|2010|56
Comparison of pulsed actinomycin D versus 5‐day methotrexate for the treatment of low‐risk gestational trophoblastic disease
|International Journal of Gynecology & Obstetrics|2011|51